Intergalactic Therapeutics

About:

Intergalactic Therapeutics is an ATP company, is revolutionizing gene therapies with a novel non-viral platform.

Website: https://www.intergalactictx.com

Top Investors: Apple Tree Partners

Description:

Intergalactic Therapeutics is an ATP company, is revolutionizing gene therapies with a novel non-viral platform comprised of its versatile synthetic and episomal C3DNA (covalently closed and circular DNA) molecules; a customized approach to focal therapeutic delivery using its lead delivery technology, the COMET® pulsed electric field system; and a proprietary cell-free manufacturing process invented to make gene therapy safer and more accessible for patients. With programs in ophthalmology, oncology, respiratory diseases, and expansion areas including CNS, renal, and musculoskeletal, Intergalactic Therapeutics is dedicated to transforming genetic medicine.

Total Funding Amount:

$75M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

2020-01-01

Founders:

Michael Ehlers

Number of Employees:

11-50

Last Funding Date:

2021-10-07

IPO Status:

Private

Industries:

© 2025 bioDAO.ai